ADiTx Therapeutics, Inc. — Regulation A 1-A/A
ADiTx Therapeutics, Inc. of Loma Linda, CA filed a Regulation A 1-A/A with the SEC on 2018-09-04. Aggregate offering: $10.0M (Tier 2). Industry: Other.
Offering
- Filed: 2018-09-04
- Form: 1-A/A
- Accession: 0001615774-18-009107
- Tier: Tier 2
- Total aggregate offering: $10.0M
- Issuer portion: $10.0M
- Price per security: $6.0000
- Securities offered: Equity (common or preferred stock), Option, warrant or other right to acquire another security
- Broker-dealer CRD: 13577
- Audit status: Audited
- Auditor: dbbmckennon
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001726711
- Organized in: DE
- Incorporated: 2017
- Address: 11161 Anderson Street, Loma Linda, CA, 92354
- Phone: 909-488-0844
- Employees: 1 full-time, 1 part-time
Financial snapshot (as filed)
- Total assets: $25K
- Cash & equivalents: $25K
- Total liabilities: $85K
- Stockholder equity: $-60K
- Net income: $-213K
People (4)
| Name | Role | Location |
|---|
| Amro Albanna | Chief Executive Officer | Richmond, VA |
| Richard Friedman | Signer | New York, NY |
| Richard A. Friedman | Signer | New York, NY |
| Richard A. Friedman, Esq. | Signer | Loma Linda, CA |
Other Reg A filings by this issuer (8)
More